News - Page 128 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Entheon Biomedical Announces Expanded Psychedelics Genetic Test Panel

Entheon Biomedical Announces Expanded Psychedelics Genetic Test Panel

Post published:December 21, 2021
Post category:Press Release

Read more about the article HAVN Life Enters into Definitive Agreement to Acquire Spore Life Sciences Inc.

HAVN Life Enters into Definitive Agreement to Acquire Spore Life Sciences Inc.

Post published:December 20, 2021
Post category:Press Release

Read more about the article Two esteemed doctors join CB Therapeutics in its exploration of innovative approaches to the production of novel psychedelics and cannabinoids so researchers can address the unmet needs of patient communities

Two esteemed doctors join CB Therapeutics in its exploration of innovative approaches to the production of novel psychedelics and cannabinoids so researchers can address the unmet needs of patient communities

Post published:December 20, 2021
Post category:Press Release

Read more about the article Psychedelic Bulletin: COMPASS’ “Infamous” Psilocybin Patent Challenged; atai Stock Price Tumbles As Lock-Up Expiry Date Arrives; UT Austin Launches Psychedelics Centre

Psychedelic Bulletin: COMPASS’ “Infamous” Psilocybin Patent Challenged; atai Stock Price Tumbles As Lock-Up Expiry Date Arrives; UT Austin Launches Psychedelics Centre

Post published:December 17, 2021
Post category:Psychedelic Bulletin

Read more about the article MYND Life Sciences Acquires Rights for the Use of Psychedelics to Treat Alzheimer’s Disease and other Dementias

MYND Life Sciences Acquires Rights for the Use of Psychedelics to Treat Alzheimer’s Disease and other Dementias

Post published:December 17, 2021
Post category:Press Release

Read more about the article MindMed Initiates Phase 2a LSD Trial for the Treatment of Adult ADHD

MindMed Initiates Phase 2a LSD Trial for the Treatment of Adult ADHD

Post published:December 17, 2021
Post category:Press Release

Read more about the article COMPASS Selected for Addition to NASDAQ Biotechnology Index

COMPASS Selected for Addition to NASDAQ Biotechnology Index

Post published:December 17, 2021
Post category:Press Release

Read more about the article Psyched Wellness Announces Path to Market for AME-1-derived Products in the USA

Psyched Wellness Announces Path to Market for AME-1-derived Products in the USA

Post published:December 16, 2021
Post category:Press Release

Read more about the article COMPASS Pathways announces changes in Executive Team

COMPASS Pathways announces changes in Executive Team

Post published:December 16, 2021
Post category:Press Release

Read more about the article MINDCURE Announces Certification of HIPAA Compliance, Bringing iSTRYM Closer to Commercial Deployment in the Second Quarter of 2022

MINDCURE Announces Certification of HIPAA Compliance, Bringing iSTRYM Closer to Commercial Deployment in the Second Quarter of 2022

Post published:December 16, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.